A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE
NCT00914966
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Hereditary Angioedema
Interventions
BIOLOGICAL:
C1 inhibitor (human) [C1 INH]
Sponsor
Shire